StreetInsider.com News Articles

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

Thu, 28 May 2026 08:30:00 -0400

ALAMEDA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present a company overview and host investor and partner meetings at the Jefferies Global Healthcare Conference taking place June 2-4, 2026 in New York, New York.

Details of Dr. Mendelsohn’s presentation are as follows:

Date: Thursday, June 4, 2026
Time: 11:05 a.m. - 11:35 a.m. Eastern Time
Location: New York Marriott Marquis, 1535 Broadway

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

Thu, 28 May 2026 08:30:00 -0400

Details of Dr. Mendelsohn’s presentation are as follows:

Date: Thursday, June 4, 2026
Time: 11:05 a.m. - 11:35 a.m. Eastern Time
Location: New York Marriott Marquis, 1535 Broadway

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

Thu, 28 May 2026 08:30:00 -0400

Details of Dr. Mendelsohn’s presentation are as follows:

Date: Thursday, June 4, 2026
Time: 11:05 a.m. - 11:35 a.m. Eastern Time
Location: New York Marriott Marquis, 1535 Broadway

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

Thu, 28 May 2026 08:30:00 -0400

Details of Dr. Mendelsohn’s presentation are as follows:

Date: Thursday, June 4, 2026
Time: 11:05 a.m. - 11:35 a.m. Eastern Time
Location: New York Marriott Marquis, 1535 Broadway

Form SCHEDULE 13D/A Vivani Medical, Inc. Filed by: Williams Gregg

Tue, 19 May 2026 13:01:00 -0400

si-local-file:///var/storage/secattach/20260519/26519952.html

Form SCHEDULE 13D/A Vivani Medical, Inc. Filed by: Williams Gregg

Tue, 19 May 2026 13:01:00 -0400

si-local-file:///var/storage/secattach/20260519/26519952.html

Form 4 Vivani Medical, Inc. For: May 15 Filed by: Williams Gregg

Tue, 19 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260519/26517969.html

Form 4 Vivani Medical, Inc. For: May 15 Filed by: Williams Gregg

Tue, 19 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260519/26517969.html

Form 8-K Vivani Medical, Inc. For: May 13

Wed, 13 May 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260513/26486584.html

Form 8-K Vivani Medical, Inc. For: May 13

Wed, 13 May 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260513/26486584.html

Form 10-Q Vivani Medical, Inc. For: Mar 31

Wed, 13 May 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260513/26486561.html

Form 10-Q Vivani Medical, Inc. For: Mar 31

Wed, 13 May 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260513/26486561.html

Vivani Medical, Inc. (VANI) Reports In-Line Q1 EPS

Wed, 13 May 2026 16:23:08 -0400

Vivani Medical, Inc. (NASDAQ: VANI) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08).

For earnings history and earnings-related data on Vivani Medical, Inc. (VANI) click here.

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Wed, 13 May 2026 16:05:00 -0400

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026

$28 million in cash, cash equivalents, restricted cash and capital commitments expected to fund current operating plan through the first half of 2027

ALAMEDA, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting subdermal drug implants utilizing its proprietary NanoPortal™ technology, today reported financial results for the first quarter ended March 31, 2026, and

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Wed, 13 May 2026 16:05:00 -0400

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026

$28 million in cash, cash equivalents, restricted cash and capital commitments expected to fund current operating plan through the first half of 2027

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Wed, 13 May 2026 16:05:00 -0400

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026

$28 million in cash, cash equivalents, restricted cash and capital commitments expected to fund current operating plan through the first half of 2027

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Wed, 13 May 2026 16:05:00 -0400

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026

$28 million in cash, cash equivalents, restricted cash and capital commitments expected to fund current operating plan through the first half of 2027

Form ARS Vivani Medical, Inc. For: Dec 31

Wed, 29 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260429/26395809.html

Form ARS Vivani Medical, Inc. For: Dec 31

Wed, 29 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260429/26395809.html

Form DEFA14A Vivani Medical, Inc.

Wed, 29 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260429/26395734.html

Form DEFA14A Vivani Medical, Inc.

Wed, 29 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260429/26395734.html

Form DEF 14A Vivani Medical, Inc. For: Dec 31

Wed, 29 Apr 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260429/26395643.html

Form DEF 14A Vivani Medical, Inc. For: Dec 31

Wed, 29 Apr 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260429/26395643.html

Form 4 Vivani Medical, Inc. For: Apr 15 Filed by: Williams Gregg

Thu, 16 Apr 2026 06:30:00 -0400

si-local-file:///var/storage/secattach/20260416/26320773.html

Form 4 Vivani Medical, Inc. For: Apr 15 Filed by: Williams Gregg

Thu, 16 Apr 2026 06:30:00 -0400

si-local-file:///var/storage/secattach/20260416/26320773.html